Comparison of Mirabegron and Vibegron in Women With Treatment-Naive Overactive Bladder: A Randomized Controlled Study.

Manami Kinjo,Kazuki Masuda,Yu Nakamura,Jimpei Miyakawa,Mitsuhiro Tambo,Hiroshi Fukuhara

Urology（2023）

引用 2|浏览2

暂无评分

摘要

Both mirabegron at 50 mg and vibegron at 50 mg improved OAB symptoms and the parameters of voiding diary equally in postmenopausal women with treatment naïve OAB.

查看译文

关键词

mirabegron,overactive bladder,treatment efficacy,vibegron

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要